CCDC28B
Coiled-coil domain-containing protein 28B
Also known as: CC28B_HUMAN, MGC1203, RP4-622L5.5
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9BUN5
- Gene
- CCDC28B
- Ensembl
- ENSG00000160050
- Chromosome
- 1
- Canonical length
- 200 aa
- Protein class
- Disease related genes, Predicted intracellular proteins
OverviewNCBI Gene
The product of this gene localizes to centrosomes and basal bodies. The protein colocalizes with several proteins associated with Bardet-Biedl syndrome (BBS) and participates in the regulation of cilia development. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2014]
Canonical amino-acid sequenceUniProt
200 residues, UniProt reviewed canonical sequence.
>Q9BUN5|CCDC28B
1 MDDKKKKRSP KPCLAQPAQA PGTLRRVPVP TSHSGSLALG LPHLPSPKQR AKFKRVGKEK
61 CRPVLAGGGS GSAGTPLQHS FLTEVTDVYE MEGGLLNLLN DFHSGRLQAF GKECSFEQLE
121 HVREMQEKLA RLHFSLDVCG EEEDDEEEED GVTEGLPEEQ KKTMADRNLD QLLSNLEDLS
181 NSIQKLHLAE NAEPEEQSAALocalizationUniProt · AlphaFold · HPA
Whether an antibody against CCDC28B can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.59
- Highest tissue expression
- 211 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 211 nTPM
- tongue: 70 nTPM
- cerebellum: 31 nTPM
- testis: 27 nTPM
- heart muscle: 26 nTPM
- pituitary gland: 24 nTPM
Single-cell type
- megakaryocytes: 309 nCPM
- tuft cells: 104 nCPM
- late spermatids: 55 nCPM
- megakaryocyte progenitors: 55 nCPM
- neuroendocrine cells: 43 nCPM
- epicardial cells: 41 nCPM
Immune cell
- NK-cell: 47 nTPM
- plasmacytoid DC: 37 nTPM
- gdT-cell: 36 nTPM
- memory CD8 T-cell: 34 nTPM
- naive B-cell: 32 nTPM
- myeloid DC: 31 nTPM
Brain region
- thalamus: 14 nTPM
- cerebellum: 11 nTPM
- amygdala: 11 nTPM
- cerebral cortex: 9.4 nTPM
- hypothalamus: 8.5 nTPM
- midbrain: 8.4 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about CCDC28B.
Disease | AllUniProt
Conditions CCDC28B is implicated in, by any mechanism.
- Bardet-Biedl syndrome (BBS) MIM:209900
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.92
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.03
- DepMap mean gene effect
- -0.19
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CCDC28B in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CCDC28B as an antibody target. Whether an autoantibody or antibody against CCDC28B could matter depends on whether native CCDC28B is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CCDC28B is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CCDC28B as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...